AU1205500A - Lysine-rich statherin protein - Google Patents

Lysine-rich statherin protein

Info

Publication number
AU1205500A
AU1205500A AU12055/00A AU1205500A AU1205500A AU 1205500 A AU1205500 A AU 1205500A AU 12055/00 A AU12055/00 A AU 12055/00A AU 1205500 A AU1205500 A AU 1205500A AU 1205500 A AU1205500 A AU 1205500A
Authority
AU
Australia
Prior art keywords
lysine
rich
statherin
protein
statherin protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12055/00A
Other languages
English (en)
Inventor
Neil C. Corley
Karl J Guegler
Chandra Patterson
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU1205500A publication Critical patent/AU1205500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU12055/00A 1998-10-23 1999-10-22 Lysine-rich statherin protein Abandoned AU1205500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15520998P 1998-10-23 1998-10-23
US60155209 1998-10-23
PCT/US1999/024046 WO2000024779A1 (fr) 1998-10-23 1999-10-22 Proteine statherine riche en lysine

Publications (1)

Publication Number Publication Date
AU1205500A true AU1205500A (en) 2000-05-15

Family

ID=22554505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12055/00A Abandoned AU1205500A (en) 1998-10-23 1999-10-22 Lysine-rich statherin protein

Country Status (5)

Country Link
EP (1) EP1124852A1 (fr)
JP (1) JP2003521872A (fr)
AU (1) AU1205500A (fr)
CA (1) CA2348046A1 (fr)
WO (1) WO2000024779A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833435B2 (en) 1999-08-23 2004-12-21 Matthew Glenn Compositions isolated from bovine tissues and methods for their use

Also Published As

Publication number Publication date
WO2000024779A1 (fr) 2000-05-04
CA2348046A1 (fr) 2000-05-04
EP1124852A1 (fr) 2001-08-22
JP2003521872A (ja) 2003-07-22

Similar Documents

Publication Publication Date Title
AU2434199A (en) Protein
AU1550300A (en) Antigen-binding proteins
AU6721696A (en) Cd44-like protein
AU6045900A (en) Interaction-activated proteins
AU5587799A (en) Protein transport-associated molecules
AU4281999A (en) Peptide
AU1744900A (en) Gtpase associated proteins
AU4930399A (en) Novel Polypeptide
AU2071799A (en) Placental protein 13
AU6000698A (en) Proteins
AU6275098A (en) Novel h-rev 107-like protein
AU2659600A (en) Adipose specific protein
AU1881200A (en) Novel proteins
AU1205500A (en) Lysine-rich statherin protein
AU1540701A (en) Novel protein
AU1184800A (en) Novel polypeptide
AU2390800A (en) Secreted proteins
AU1552800A (en) Coupled peptides
AU6692198A (en) Novel proline-rich acidic protein
AU2002500A (en) Novel protein
AU7304600A (en) Novel protein
AU6522199A (en) Secreted protein zsig49
AU4438599A (en) Human arf-related proteins
AUPP460498A0 (en) Modified proteins
AU6444600A (en) New protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase